Demant A/S (LON:0RGT)

Market Cap	4.55B -24.3%
Revenue (ttm)	2.68B +2.5%
Net Income	180.47M -35.3%
EPS	0.85 -33.5%
Shares Out	n/a
PE Ratio	25.23
Forward PE	14.89
Dividend	n/a
Ex-Dividend Date	n/a

Volume	65,782
Average Volume	48,422
Open	189.75
Previous Close	189.20
Day's Range	184.30 - 188.50
52-Week Range	175.00 - 292.80
Beta	0.82
RSI	48.72
Earnings Date	Aug 11, 2026

About Demant

Demant A/S operates as a hearing healthcare company in Europe, North America, Asia, Pacific region, and internationally. It engages in the development, manufacture, and wholesale of hearing aids; owning and operating hearing care clinics; and offers hearing and balance assessment solutions used by audiologists, ENT doctors, and balance clinics. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1904
• Employees: 25,077
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0RGT

Financial Performance

In 2025, Demant's revenue was 22.97 billion, an increase of 2.46% compared to the previous year's 22.42 billion. Earnings were 1.55 billion, a decrease of -35.27%.

Financial numbers in DKK